Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiogenesis
Cancer center enrolling patients for colorectal cancer clinical trials
October 27th, 2003
Spectrum Health Cancer Center officials are enrolling patients for two new clinical research trials for colorectal cancer. They will test a new drug's ability to limit or halt the growth of new blood vessels in tumors and are looking for patients who wish to participate. The studies are called CONFIRM 1 and CONFIRM 2, an acronym of Colorectal Oral Novel Therapy for the Inhibition of Angiogenesis and Retarding of Metastases. It is hoped the drug will promote anti-angiogenesis. Tumor angiogenesis is the rapid growth of a network of blood vessels that penetrates into cancerous growths, which allows the tumor to grow and spread. This drug may interfere...
Source: Health & Medicine Week (2003-10-27)
|
